MENLO PARK, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced the appointment of Christopher ...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
PACB teams with DNAstack to launch a global HiFi genome network, linking 10,000+ sequences to boost rare disease research ...
MENLO PARK, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in ...
PacBio has announced its participation in the 1000 Genomes Long Read Sequencing Project, contributing long-read transcriptome data to enhance this significant human genomics initiative. Through ...
MENLO PARK, Calif., Oct. 31, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun taking orders for its ...
StockStory.org on MSN
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes shares are falling, what you need to know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced an expanded partnership with seqWell yesterday. Under the new agreement, PacBio will distribute seqWell’s LongPlex ...
The National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate genomic and epigenomic data from as many as 7,800 participants. The effort will rely on PacBio’s ...
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif., Sept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results